Others have, using various animal models, demonstrated beneficial effects of TLR7 agonists in allergic asthma [33] and a recent clinical trial has shown encouraging results, suggesting that TLR7 agonists might be a novel alternative for treatment of allergic rhinitis [34]. This evidence concerns the gene TLR7 and allergic rhinitis.